{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:27:37Z","timestamp":1790796457043,"version":"4.1.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Immune-mediated cerebellar ataxias (IMCAs) have diverse etiologies. Patients with IMCAs develop cerebellar symptoms, characterized mainly by gait ataxia, showing an acute or subacute clinical course. We present a novel concept of latent autoimmune cerebellar ataxia (LACA), analogous to latent autoimmune diabetes in adults (LADA). LADA is a slowly progressive form of autoimmune diabetes where patients are often initially diagnosed with type 2 diabetes. The sole biomarker (serum anti-GAD antibody) is not always present or can fluctuate. However, the disease progresses to pancreatic beta-cell failure and insulin dependency within about 5 years. Due to the unclear autoimmune profile, clinicians often struggle to reach an early diagnosis during the period when insulin production is not severely compromised. LACA is also characterized by a slowly progressive course, lack of obvious autoimmune background, and difficulties in reaching a diagnosis in the absence of clear markers for IMCAs. The authors discuss two aspects of LACA: (<jats:italic>1<\/jats:italic>) the <jats:italic>not manifestly evident autoimmunity<\/jats:italic> and (<jats:italic>2<\/jats:italic>) the <jats:italic>prodromal stage of IMCA\u2019s<\/jats:italic> characterized by a period of partial neuronal dysfunction where non-specific symptoms may occur. In order to achieve an early intervention and prevent cell death in the cerebellum, identification of the time-window before irreversible neuronal loss is critical. LACA occurs during this time-window when possible preservation of neural plasticity exists. Efforts should be devoted to the early identification of biological, neurophysiological, neuropsychological, morphological (brain morphometry), and multimodal biomarkers allowing early diagnosis and therapeutic intervention and to avoid irreversible neuronal loss.<\/jats:p>","DOI":"10.1007\/s12311-023-01550-4","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T21:02:38Z","timestamp":1680123758000},"page":"838-855","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Consensus Paper: Latent Autoimmune Cerebellar Ataxia (LACA)"],"prefix":"10.1007","volume":"23","author":[{"given":"Mario","family":"Manto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Hadjivassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Fidel","family":"Baizabal-Carvallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane S","family":"Hampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0513-1811","authenticated-orcid":false,"given":"Hiroshi","family":"Mitoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Mu\u00f1iz-Castrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasef G.","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Vogrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"1550_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/B978-0-444-51892-7.00011-5","volume":"103","author":"M Hadjivassiliou","year":"2012","unstructured":"Hadjivassiliou M. Immune-mediated acquired ataxias. Handb Clin Neurol. 2012;103:189\u201399.","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"1550_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12311-015-0664-x","volume":"15","author":"H Mitoma","year":"2016","unstructured":"Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS, et al. Consensus paper: neuroimmune mechanisms of cerebellar ataxias. Cerebellum. 2016;15(2):213\u201332.","journal-title":"Cerebellum."},{"key":"1550_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40673-015-0034-y","volume":"2","author":"H Mitoma","year":"2015","unstructured":"Mitoma H, Hadjivassiliou M, Honnorat J. Guidelines for treatment of immune-mediated cerebellar ataxias. Cerebellum Ataxias. 2015;2:14.","journal-title":"Cerebellum Ataxias"},{"key":"1550_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/B978-0-444-64189-2.00021-4","volume":"155","author":"B Joubert","year":"2018","unstructured":"Joubert B, Rot\u00e1sky J, Honnorat J. Nonparaneoplastic autoimmune cerebellar ataxia. Handb Clin Neurol. 2018;155:313\u201332.","journal-title":"Handb Clin Neurol"},{"key":"1550_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/978-3-030-19515-1_19","volume-title":"Neuroimmune diseases; from cells to the living brain","author":"M Hadjivassiliou","year":"2019","unstructured":"Hadjivassiliou M, Mitoma H, Manto M. Autoimmune ataxia. In: Mitoma H, Manto M, editors. Neuroimmune diseases; from cells to the living brain. Springer Nature; 2019. p. 599\u2013620."},{"issue":"1","key":"1550_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14802\/jmd.20040","volume":"14","author":"H Mitoma","year":"2021","unstructured":"Mitoma H, Manto M, Hadjivassiliou M. Immune-mediated cerebellar ataxias: clinical diagnosis and treatment based on immunological and physiological mechanisms. J Mov Disord. 2021;14(1):10\u201328.","journal-title":"J Mov Disord"},{"issue":"4","key":"1550_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s12311-020-01132-8","volume":"19","author":"M Hadjivassiliou","year":"2020","unstructured":"Hadjivassiliou M, Graus F, Honnorat J, Jarius S, Titulaer M, Manto M, Hoggard N, Sarrigiannis P, Mitoma H. Diagnostic criteria for primary autoimmune cerbellar ataxia (PACA)-guidlines from an International Task Force on Immune Mediated Cerbellar Ataxia. Cerebellum. 2020;19(4):605\u201310.","journal-title":"Cerebellum."},{"issue":"2","key":"1550_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12311-012-0411-5","volume":"12","author":"K Nanri","year":"2013","unstructured":"Nanri K, Niwa H, Mitoma H, Takei A, Ikeda J, Harada T, et al. Low-titer anti-GAD-antibody-positive cerebellar ataxia. Cerebellum. 2013;12(2):171\u20135.","journal-title":"Cerebellum."},{"issue":"10","key":"1550_CR9","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00702-017-1754-3","volume":"124","author":"JF Baizabal-Carvallo","year":"2017","unstructured":"Baizabal-Carvallo JF, Alonso-Juarez M. Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review. A J Neural Transm (Vienna). 2017;124(10):1171\u201382.","journal-title":"A J Neural Transm (Vienna)"},{"issue":"4","key":"1550_CR10","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s12311-017-0851-z","volume":"16","author":"T Petrijan","year":"2017","unstructured":"Petrijan T, Menih M. Low-Titre GAD Antibody-associated late-onset cerebellar ataxia with a significant clinical response to intravenous immunoglobulin treatment. Cerebellum. 2017;16(4):868\u201371.","journal-title":"Cerebellum."},{"issue":"5","key":"1550_CR11","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s12311-020-01159-x","volume":"19","author":"S Mu\u00f1iz-Castrillo","year":"2020","unstructured":"Mu\u00f1iz-Castrillo S, Vogrig A, Joubert B, Pinto AL, Gon\u00e7alves D, Chaumont H, et al. Transient neurological symptoms preceding cerebellar ataxia with glutamic acid decarboxylase antibodies. Cerebellum. 2020;19(5):715\u201321.","journal-title":"Cerebellum."},{"issue":"2","key":"1550_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2337\/diab.42.2.359","volume":"42","author":"T Tuomi","year":"1993","unstructured":"Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes. 1993;42(2):359\u201362.","journal-title":"Diabetes."},{"issue":"Suppl 2","key":"1550_CR13","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.2337\/diabetes.54.suppl_2.S68","volume":"54","author":"G Stenstr\u00f6m","year":"2005","unstructured":"Stenstr\u00f6m G, Gotts\u00e4ter A, Bakhtadze E, Berger B, Sundkvist G. Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment. Diabetes. 2005;54(Suppl 2):S68\u201372.","journal-title":"Diabetes"},{"key":"1550_CR14","doi-asserted-by":"publisher","first-page":"e0155643","DOI":"10.1371\/journal.pone.0155643","volume":"11","author":"J Yasui","year":"2016","unstructured":"Yasui J, Kawasaki E, Tanaka S, Awata T, Ikegami H, Imagawa A, et al. Clinical and genetic characteristics of non-insulin-requiring glutamic acid decarboxylase (GAD) autoantibody-positive diabetes: a nationwide survey in Japan. PLoS One. 2016;11:e0155643.","journal-title":"PLoS One"},{"issue":"6","key":"1550_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/dmrr.2779","volume":"32","author":"G Huang","year":"2016","unstructured":"Huang G, Yin M, Xiang Y, Li X, Shen W, Luo S, et al. Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up. Diabetes Metab Res Rev. 2016;32(6):615\u201322.","journal-title":"Diabetes Metab Res Rev"},{"key":"1550_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fphys.2019.00320","volume":"10","author":"S Carlsson","year":"2019","unstructured":"Carlsson S. Etiology and pathogenesis of latent autoimmune diabetes in adults (LADA) compared to type 2 diabetes. Front Physiol. 2019;10:320.","journal-title":"Front Physiol"},{"issue":"1","key":"1550_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12311-019-01091-9","volume":"19","author":"H Mitoma","year":"2019","unstructured":"Mitoma H, Buffo A, Gelfo F, Guell X, Fuc\u00e0 E, Kakei S, et al. Consensus paper. Cerebellar reserve: from cerebellar physiology to cerebellar disorders. Cerebellum. 2019;19(1):131\u201353.","journal-title":"Cerebellum"},{"key":"1550_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41582-020-0359-x","volume":"16","author":"F Graus","year":"2020","unstructured":"Graus F, Saiz A, Dalmau J. GAD antibodies in neurological disorders-insights and challenges. Nat Rev Neurol. 2020;16:353\u201365.","journal-title":"Nat Rev Neurol"},{"key":"1550_CR19","doi-asserted-by":"crossref","unstructured":"Kikuchi A, Yoneda M, Hasegawa T, Matsunaga A, Ikawa M, Nakamura T, et al. High prevalence of serum anti-NH2-terminal \u03b1-enolase antibodies un patients with multiple system atrophy and corticobasal syndrome. J Neurol. 268(11):4291\u20135.","DOI":"10.1007\/s00415-021-10553-2"},{"issue":"6","key":"1550_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1159\/000510951","volume":"49","author":"TG Siddiqui","year":"2020","unstructured":"Siddiqui TG, Whitfield T, Praharaju SJ, Sadiq D, Kazmi H, Ben-Joseph A, et al. Magnetic resonance imaging in stable mild cognitive impairment, prodromal Alzheimer\u2019s disease, and prodromal dementia with Lewy bodies. Dement Geriatr Cogn Disord. 2020;49(6):583\u20138.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"1550_CR21","first-page":"104","volume":"160","author":"O Lavan","year":"2021","unstructured":"Lavan O, Apter A, Benaroya-Milshtein N, Fennig S. The prodrome of psychotic disorders. Harefuah. 2021;160(2):104\u20139.","journal-title":"Harefuah."},{"issue":"4","key":"1550_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s12311-020-01127-5","volume":"19","author":"CC Chen","year":"2020","unstructured":"Chen CC, Yao NW, Lin CW, Su WS, Wu CT, Chang C, et al. Neuroimaging spectrum at pre-, early, and late symptomatic stages of SCA 17 mice. Cerebellum. 2020;19(4):487\u2013500.","journal-title":"Cerebellum."},{"issue":"2","key":"1550_CR23","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/mds.28343","volume":"36","author":"L Vel\u00e1zquez-P\u00e9rez","year":"2021","unstructured":"Vel\u00e1zquez-P\u00e9rez L, Rodriguez-Labrada R, Gonz\u00e1lez-Garc\u00e9s Y, Arrufat-Pie E, Torres-Vega R, Medrano-Montero J, et al. Prodromal spinocerebellar ataxia type 2 subjects have quantifiable gait and postural sway deficits. Mov Disord. 2021;36(2):471\u201380.","journal-title":"Mov Disord"},{"issue":"4","key":"1550_CR24","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/mds.28466","volume":"36","author":"CM de Oliveira","year":"2021","unstructured":"de Oliveira CM, Leotti VB, Bolzan G, Cappelli AH, Rocha AG, Ecco G, et al. Pre-ataxic changes of clinical scales and eye movement in Machado-Joseph disease: BIGPRO study. Mov Disord. 2021;36(4):985\u201394.","journal-title":"Mov Disord"},{"issue":"9","key":"1550_CR25","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S1474-4422(20)30235-0","volume":"19","author":"H Jacobi","year":"2020","unstructured":"Jacobi H, du Montcel ST, Romanzetti S, Harmuth F, Mariotti C, Nanetti L, et al. Conversion of individuals at risk for spinocerebellar ataxia type 1,2,3,and 6 to manifest ataxia (RISCA): longitudinal cohort study. Lancet Neurol. 2020;19(9):738\u201347.","journal-title":"Lancet Neurol"},{"issue":"5","key":"1550_CR26","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2337\/diacare.16.5.780","volume":"16","author":"T Kobayashi","year":"1993","unstructured":"Kobayashi T, Tamemoto K, Nakanishi K, Kato N, Okubo M, Kajio H, et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care. 1993;16(5):780\u20138.","journal-title":"Diabetes Care"},{"issue":"3","key":"1550_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1464-5491.1994.tb00275.x","volume":"118","author":"PZ Zimmet","year":"1994","unstructured":"Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med. 1994;118(3):299\u2013303.","journal-title":"Diabet Med"},{"issue":"1","key":"1550_CR28","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1111\/j.1468-1331.2009.02839.x","volume":"17","author":"V Nociti","year":"2010","unstructured":"Nociti V, Frisullo G, Tartaglione T, Patanella AK, Iorio R, Tonali PA, et al. Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. Eur J Neurol. 2010;17(1):e5.","journal-title":"Eur J Neurol"},{"issue":"1","key":"1550_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1136\/jnnp.2007.142745","volume":"80","author":"R Virgilio","year":"2009","unstructured":"Virgilio R, Corti S, Agazzi P, Santoro D, Lanfranconi S, Candelise L, et al. Effect of steroid treatment in cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies. J Neurol Neurosurg Psychiatry. 2009;80(1):95\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1550_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jneuroim.2015.11.012","volume":"290","author":"JS Sunwoo","year":"2016","unstructured":"Sunwoo JS, Chu K, Byun JI, Moon J, Lim JA, Kim TJ, Lee ST, Jung KH, Park KI, Jeon D, Jung KY, Kim M, Lee SK. Intrathecal-specific glutamic acid decarboxylase antibodies at low titers in autoimmune neurological disorders. J Neuroimmunol. 2016;290:15\u201321.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"1550_CR31","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/jamaneurol.2014.1011","volume":"71","author":"H Ari\u00f1o","year":"2014","unstructured":"Ari\u00f1o H, Gresa-Arribas N, Blanco Y, Mart\u00ednez-Hern\u00e1ndez E, Sabater L, Petit-Pedrol M, Rouco I, Bataller L, Dalmau JO, Saiz A, Graus F. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. JAMA Neurol. 2014;71(8):1009\u201316.","journal-title":"JAMA Neurol"},{"key":"1550_CR32","doi-asserted-by":"publisher","first-page":"2913297","DOI":"10.1155\/2017\/2913297","volume":"2017","author":"H Mitoma","year":"2017","unstructured":"Mitoma H, Manto M, Hampe CS. Pathogenic roles of glutamic acid decarboxylase 65 autoantibodies in cerebellar ataxias. J Immunol Res. 2017;2017:2913297.","journal-title":"J Immunol Res"},{"key":"1550_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jaut.2019.04.007","volume":"101","author":"JF Baizabal-Carvallo","year":"2019","unstructured":"Baizabal-Carvallo JF. The neurological syndromes associated with glutamic acid decarboxylase antibodies. J Autoimmun. 2019;101:35\u201347.","journal-title":"J Autoimmun"},{"issue":"3","key":"1550_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/jnnp.73.3.345","volume":"73","author":"S Matsumoto","year":"2002","unstructured":"Matsumoto S, Kusuhara T, Nakajima M, Ouma S, Takahashi M, Yamada T. Acute attacks and brain stem signs in a patient with glutamic acid decarboxylase autoantibodies. J Neurol Neurosurg Psychiatry. 2002;73(3):345\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1550_CR35","doi-asserted-by":"publisher","unstructured":"Mu\u00f1iz-Castrillo S, Vogrig A, Montagnac C, Joubert B, Benaiteau M, Casez O, et al. Familial autoimmunity in neurological patients with GAD65 antibodies: an interview-based study. J Neurol. 2021; https:\/\/doi.org\/10.1007\/s00415-021-10424-w.","DOI":"10.1007\/s00415-021-10424-w"},{"issue":"6289","key":"1550_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/347151a0","volume":"347","author":"S Baekkeskov","year":"1990","unstructured":"Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 1990;347(6289):151\u20136.","journal-title":"Nature."},{"issue":"2","key":"1550_CR37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2337\/diab.44.2.216","volume":"44","author":"K Daw","year":"1995","unstructured":"Daw K, Powers AC. Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes. Diabetes. 1995;44(2):216\u201320.","journal-title":"Diabetes."},{"issue":"3","key":"1550_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1046\/j.1365-2249.1999.01030.x","volume":"118","author":"AC Powers","year":"1999","unstructured":"Powers AC, Bavik K, Tremble J, Daw K, Scherbaum WA, Banga JP. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders. Clin Exp Immunol. 1999;118(3):349\u201356.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"1550_CR39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2337\/diab.42.4.631","volume":"42","author":"WA Hagopian","year":"1993","unstructured":"Hagopian WA, Michelsen B, Karlsen AE, Larsen F, Moody A, Grubin CE, Rowe R, Petersen J, McEvoy R, Lernmark A. Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes. 1993;42(4):631\u20136.","journal-title":"Diabetes."},{"key":"1550_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fnbeh.2015.00078","volume":"9","author":"M Manto","year":"2015","unstructured":"Manto M, Honnorat J, Hampe CS, Guerra-Narbona R, L\u00f3pez-Ramos JC, Delgado-Garc\u00eda JM, Saitow F, Suzuki H, Yanagawa Y, Mizusawa H, Mitoma H. Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission. Front Behav Neurosci. 2015;9:78.","journal-title":"Front Behav Neurosci"},{"issue":"1","key":"1550_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13023-018-0787-5","volume":"13","author":"S Liimatainen","year":"2018","unstructured":"Liimatainen S, Honnorat J, Pittock SJ, McKeon A, Manto M, Radtke JR, T1D Exchange Biobank, Hampe CS. GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies. Orphanet J Rare Dis. 2018;13(1):55.","journal-title":"Orphanet J Rare Dis"},{"key":"1550_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jneuroim.2015.03.009","volume":"281","author":"P Fouka","year":"2015","unstructured":"Fouka P, Alexopoulos H, Akrivou S, Trohatou O, Politis PK, Dalakas MC. GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders. J Neuroimmunol. 2015;281:73\u20137.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"1550_CR43","doi-asserted-by":"publisher","first-page":"e0121364","DOI":"10.1371\/journal.pone.0121364","volume":"10","author":"N Gresa-Arribas","year":"2015","unstructured":"Gresa-Arribas N, Ari\u00f1o H, Mart\u00ednez-Hern\u00e1ndez E, Petit-Pedrol M, Sabater L, Saiz A, Dalmau J, Graus F. Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity. PLoS One. 2015;10(3):e0121364.","journal-title":"PLoS One"},{"issue":"8","key":"1550_CR44","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75(8):1135\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1550_CR45","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","volume":"8","author":"F Graus","year":"2021","unstructured":"Graus F, Vogrig A, Mu\u00f1iz-Castrillo S, Antoine JG, Desestret V, Dubey D, et al. Updated diagnostic criteria for paraneoplastic neurological syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8(4):e1014.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"1550_CR46","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/archneurol.2009.341","volume":"67","author":"B Giometto","year":"2010","unstructured":"Giometto B. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol. 2010;67(3):330.","journal-title":"Arch Neurol"},{"issue":"1","key":"1550_CR47","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11060-015-1898-7","volume":"125","author":"MA Kanikannan","year":"2015","unstructured":"Kanikannan MA, Sirisha Y, Uppin MS, Jabeen SA, M Kandadai R, Sundaram C, et al. Incidence and spectrum of paraneoplastic neurological syndromes: single center study. J Neuro-Oncol. 2015;125(1):197\u2013206.","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"1550_CR48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00415-019-09544-1","volume":"267","author":"A Vogrig","year":"2020","unstructured":"Vogrig A, Gigli GL, Segatti S, Corazza E, Marini A, Bernardini A, et al. Epidemiology of paraneoplastic neurological syndromes: a population-based study. J Neurol. 2020;267(1):26\u201335.","journal-title":"J Neurol"},{"issue":"6","key":"1550_CR49","doi-asserted-by":"publisher","first-page":"e883","DOI":"10.1212\/NXI.0000000000000883","volume":"7","author":"J H\u00e9bert","year":"2020","unstructured":"H\u00e9bert J, Riche B, Vogrig A, Mu\u00f1iz-Castrillo S, Joubert B, Picard G, et al. Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France. Neurol Neuroimmunol Neuroinflamm. 2020;7(6):e883.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1550_CR50","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3389\/fimmu.2020.00991","volume":"11","author":"L Yshii","year":"2020","unstructured":"Yshii L, Bost C, Liblau R. Immunological bases of paraneoplastic cerebellar degeneration and therapeutic implications. Front Immunol. 2020;11:991.","journal-title":"Front Immunol"},{"issue":"Pt6","key":"1550_CR51","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/brain\/awg133","volume":"126","author":"S Shams\u2019ili","year":"2003","unstructured":"Shams\u2019ili S, Grefkens J, de Leeuw B, van den Bent M, Hooijkaas H, van der Holt B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain. 2003;126(Pt6):1409\u201318.","journal-title":"Brain."},{"issue":"5","key":"1550_CR52","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/ene.12368","volume":"21","author":"F Ducray","year":"2014","unstructured":"Ducray F, Demarquay G, Graus F, Decullier E, Antoine J-C, Giometto B, et al. Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience. Eur J Neurol. 2014;21(5):731\u20135.","journal-title":"Eur J Neurol"},{"issue":"2","key":"1550_CR53","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1212\/01.WNL.0000041495.87539.98","volume":"60","author":"F Bernal","year":"2003","unstructured":"Bernal F, Shams\u2019ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, et al. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin\u2019s disease. Neurology. 2003;60(2):230\u20134.","journal-title":"Neurology."},{"issue":"6","key":"1550_CR54","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ana.23550","volume":"71","author":"E de Graaff","year":"2012","unstructured":"de Graaff E, Maat P, Hulsenboom E, van den Berg R, van den Bent M, Demmers J, et al. Identification of delta\/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. Ann Neurol. 2012;71(6):815\u201324.","journal-title":"Ann Neurol"},{"issue":"Pt6","key":"1550_CR55","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","volume":"124","author":"F Graus","year":"2001","unstructured":"Graus F. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124(Pt6):1138\u201348.","journal-title":"Brain."},{"issue":"5","key":"1550_CR56","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ana.10518","volume":"53","author":"SJ Pittock","year":"2003","unstructured":"Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol. 2003;53(5):580\u20137.","journal-title":"Ann Neurol"},{"issue":"3","key":"1550_CR57","doi-asserted-by":"publisher","first-page":"e699","DOI":"10.1212\/NXI.0000000000000699","volume":"7","author":"C Simard","year":"2020","unstructured":"Simard C, Vogrig A, Joubert B, Mu\u00f1iz-Castrillo S, Picard G, Rogemond V, et al. Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies. Neurol Neuroimmunol Neuroinflamma. 2020;7(3):e699.","journal-title":"Neurol Neuroimmunol Neuroinflamma"},{"issue":"Pt8","key":"1550_CR58","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/brain\/awh203","volume":"127","author":"J Dalmau","year":"2004","unstructured":"Dalmau J. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004;127(Pt8):1831\u201344.","journal-title":"Brain."},{"issue":"11","key":"1550_CR59","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1001\/jamaneurol.2020.2231","volume":"77","author":"D Dubey","year":"2020","unstructured":"Dubey D, Wilson MR, Clarkson B, Giannini C, Gandhi M, Cheville J, et al. Expanded clinical phenotype, oncological associations, and immunopathologic insights of paraneoplastic Kelch-like protein-11 encephalitis. JAMA Neurol. 2020;77(11):1420\u20139.","journal-title":"JAMA Neurol"},{"issue":"2","key":"1550_CR60","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s12311-018-0987-5","volume":"18","author":"LD Do","year":"2019","unstructured":"Do LD, Gupton SL, Tanji K, Bastien J, Brugi\u00e8re S, Cout\u00e9 Y, et al. TRIM9 and TRIM67 are new targets in paraneoplastic cerebellar degeneration. Cerebellum. 2019;18(2):245\u201354.","journal-title":"Cerebellum"},{"issue":"2","key":"1550_CR61","doi-asserted-by":"publisher","first-page":"e658","DOI":"10.1212\/NXI.0000000000000658","volume":"7","author":"R Ruiz-Garc\u00eda","year":"2019","unstructured":"Ruiz-Garc\u00eda R, Mart\u00ednez-Hern\u00e1ndez E, Joubert B, Petit-Pedrol M, Pajar\u00f3n-Boix E, Fern\u00e1ndez V, et al. Paraneoplastic cerebellar ataxia and antibodies to metabotropic glutamate receptor 2. Neurol Neuroimmunol Neuroinflamm. 2019;7(2):e658.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"10","key":"1550_CR62","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1212\/WNL.42.10.1931","volume":"42","author":"K Peterson","year":"1992","unstructured":"Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology. 1992;42(10):1931\u20137.","journal-title":"Neurology."},{"issue":"5","key":"1550_CR63","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s12311-019-01075-9","volume":"18","author":"A Vogrig","year":"2019","unstructured":"Vogrig A, Bernardini A, Gigli GL, Corazza E, Marini A, Segatti S, et al. Stroke-like presentation of paraneoplastic cerebellar degeneration: a single-center experience and review of the literature. Cerebellum. 2019;18(5):976\u201382.","journal-title":"Cerebellum."},{"issue":"3","key":"1550_CR64","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1212\/WNL.50.3.652","volume":"50","author":"CF Lucchinetti","year":"1998","unstructured":"Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology. 1998;50(3):652\u20137.","journal-title":"Neurology."},{"key":"1550_CR65","doi-asserted-by":"publisher","first-page":"e604","DOI":"10.1212\/NXI.0000000000000604","volume":"6","author":"A Vogrig","year":"2019","unstructured":"Vogrig A, Fouret M, Joubert B, Picard G, Rogemond V, Pinto A-L, et al. Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors. Neurol Neuroimmunol NeuroInflamm. 2019;6:e604.","journal-title":"Neurol Neuroimmunol NeuroInflamm"},{"key":"1550_CR66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jneuroim.2018.01.013","volume":"317","author":"JF Baizabal-Carvallo","year":"2018","unstructured":"Baizabal-Carvallo JF, Alonso-Juarez M. Vertical nystagmus associated with glutamic acid decarboxylase antibodies responding to cyclophosphamide. J Neuroimmunol. 2018;317:5\u20137.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"1550_CR67","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12311-018-0972-z","volume":"18","author":"D Feldman","year":"2019","unstructured":"Feldman D, Otero-Millan J, Shaikh AG. Gravity-independent upbeat nystagmus in syndrome of anti-GAD antibodies. Cerebellum. 2019;18(2):287\u201390.","journal-title":"Cerebellum."},{"issue":"3","key":"1550_CR68","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1590\/0004-282x20170011","volume":"75","author":"TS Aguiar","year":"2017","unstructured":"Aguiar TS, Fragoso A, Albuquerque CR, Teixeira PF, Souza MV, Zajdenverg L, et al. Clinical characteristics of patients with cerebellar ataxia associated with anti-GAD antibodies. Arq Neuropsiquiatr. 2017;75(3):142\u20136.","journal-title":"Arq Neuropsiquiatr"},{"issue":"6","key":"1550_CR69","first-page":"e4851","volume":"11","author":"FM Yilmaz","year":"2019","unstructured":"Yilmaz FM, Little D, Gallagher M, Colcher A. Anti-glutamate dehydrogenase antibody positive cerebellar ataxia and stiff person syndrome responding to dual treatment with steroids and intravenous immunoglobulin: a case presentation and literature review. Cureus. 2019;11(6):e4851.","journal-title":"Cureus."},{"issue":"1-2","key":"1550_CR70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0022-510X(96)00065-2","volume":"143","author":"B Giometto","year":"1996","unstructured":"Giometto B, Miotto D, Faresin F, Argentiero V, Scaravilli T, Tavolato B. Anti-gabaergic neuron autoantibodies in a patient with stiff-man syndrome and ataxia. J Neurol Sci. 1996;143(1-2):57\u20139.","journal-title":"J Neurol Sci"},{"issue":"3","key":"1550_CR71","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1600-0404.2010.01356.x","volume":"123","author":"M Hadjivassiliou","year":"2011","unstructured":"Hadjivassiliou M, Aeschlimann D, Gr\u00fcnewald RA, Sanders DS, Sharrack B, Woodroofe N. GAD antibody-associated neurological illness and its relationship to gluten sensitivity. Acta Neurol Scand. 2011;123(3):175\u201380.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"1550_CR72","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s12311-020-01203-w","volume":"20","author":"M Hadjivassiliou","year":"2021","unstructured":"Hadjivassiliou M, Sarrigiannis PG, Shanmugarajah PD, Sanders DS, Gr\u00fcnewald RA, Zis P, Hoggard N. Clinical characteristics and management of 50 patients with anti-GAD ataxia: gluten-free diet has a major impact. Cerebellum. 2021;20(2):179\u201385.","journal-title":"Cerebellum"},{"issue":"2","key":"1550_CR73","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/archneur.58.2.225","volume":"58","author":"J Honnorat","year":"2001","unstructured":"Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol. 2001;58(2):225\u201330.","journal-title":"Arch Neurol"},{"key":"1550_CR74","first-page":"3431849","volume":"2016","author":"IE Dagklis","year":"2016","unstructured":"Dagklis IE, Papagiannopoulos S, Theodoridou V, Kazis D, Argyropoulou O, Bostantjopoulou S. Miller-Fisher syndrome: are anti-GAD antibodies implicated in its pathophysiology? Case Rep Neurol Med. 2016;2016:3431849.","journal-title":"Case Rep Neurol Med"},{"issue":"6","key":"1550_CR75","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1590\/S0004-282X2011000700030","volume":"69","author":"JL Pedroso","year":"2011","unstructured":"Pedroso JL, Braga-Neto P, Dutra LA, Barsottini OG. Cerebellar ataxia associated to anti-glutamic acid decarboxylase autoantibody (anti-GAD): partial improvement with intravenous immunoglobulin therapy. Arq Neuropsiquiatr. 2011;69(6):993.","journal-title":"Arq Neuropsiquiatr"},{"issue":"10","key":"1550_CR76","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2169\/internalmedicine.48.1802","volume":"48","author":"K Nanri","year":"2009","unstructured":"Nanri K, Okita M, Takeguchi M, Taguchi T, Ishiko T, Saito H, et al. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia. Intern Med. 2009;48(10):783\u201390.","journal-title":"Intern Med"},{"issue":"10","key":"1550_CR77","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1001\/archneurol.2011.128","volume":"68","author":"A McKeon","year":"2011","unstructured":"McKeon A. Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. Arch Neurol. 2011;68(10):1282\u20139.","journal-title":"Arch Neurol"},{"issue":"1","key":"1550_CR78","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/brain\/awx317","volume":"141","author":"F Hoche","year":"2018","unstructured":"Hoche F, Guell X, Vangel MG, Sherman JC, Schmahmann JD. The cerebellar cognitive affective\/Schmahmann syndrome scale. Brain J Neurol. 2018;141(1):248\u201370.","journal-title":"Brain J Neurol"},{"issue":"6","key":"1550_CR79","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1056\/NEJMcpc069035","volume":"356","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, Gonzalez RG, Lerwill MF. A 56-year-old woman with rapidly progressive vertigo and ataxia. N Engl J Med. 2007;356(6):612\u201320.","journal-title":"N Engl J Med"},{"key":"1550_CR80","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s10072-011-0648-7","volume":"32","author":"E Ogawa","year":"2011","unstructured":"Ogawa E, Sakakibara R, Kawashima K, Yoshida T, Kishi M, Tateno F, et al. VGCC antibody-positive paraneoplastic cerebellar degeneration presenting with positioning vertigo. Neurol Sci. 2011;32:1209\u201312.","journal-title":"Neurol Sci"},{"issue":"3","key":"1550_CR81","doi-asserted-by":"publisher","first-page":"fcab185","DOI":"10.1093\/braincomms\/fcab185","volume":"3","author":"A Vogrig","year":"2021","unstructured":"Vogrig A, P\u00e9ricart S, Pinto AL, Rogemond V, Mu\u00f1iz-Castrillo S, Picard G, et al. Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis. Brain Commun. 2021;3(3):fcab185.","journal-title":"Brain Commun"},{"issue":"4","key":"1550_CR82","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00401-017-1802-y","volume":"135","author":"M Small","year":"2018","unstructured":"Small M, Treilleux I, Couillault C, Pissaloux D, Picard G, Paindavoine S, et al. Genetic alterations and tumor immune attack in Yo paraneoplasctic cerebellar degeneration. Acta Neuropathol. 2018;135(4):569\u201379.","journal-title":"Acta Neuropathol"},{"issue":"9140","key":"1550_CR83","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/S0140-6736(98)05342-2","volume":"352","author":"M Hadjivassiliou","year":"1998","unstructured":"Hadjivassiliou M, Gr\u00fcnewald RA, Chattopadhyay AK, Davies-Jones GA, Gibson A, Jarratt JA, et al. Clinical, radiological, neurophysiological and neuropathological characteristics of gluten ataxia. Lancet. 1998;352(9140):1582\u20135.","journal-title":"Lancet."},{"issue":"3","key":"1550_CR84","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1474-4422(09)70290-X","volume":"9","author":"M Hadjivassiliou","year":"2010","unstructured":"Hadjivassiliou M, Sanders DS, Grunewald RA, Woodroofe N, Boscolo S, Aeschlimann D. Gluten sensitivity: from gut to brain. Lancet Neurol. 2010;9(3):318\u201330.","journal-title":"Lancet Neurol"},{"issue":"19","key":"1550_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.0b013e3182919070","volume":"80","author":"M Hadjivassiliou","year":"2013","unstructured":"Hadjivassiliou M, Aeschlimann P, Sanders DS, M\u00e4ki M, Kaukinen K, Gr\u00fcnewald RA, et al. Transglutaminase 6 antibodies in the diagnosis of gluten ataxia. Neurology. 2013;80(19):1\u20136.","journal-title":"Neurology."},{"issue":"7","key":"1550_CR86","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1212\/WNL.0000000000004237","volume":"89","author":"M Hadjivassiliou","year":"2017","unstructured":"Hadjivassiliou M, Gr\u00fcnewald RA, Sanders DS, Shanmugarajah P, Hoggard N. Effect of gluten-free diet on cerebellar MR spectroscopy in gluten ataxia. Neurolgy. 2017;89(7):705\u20136.","journal-title":"Neurolgy"},{"issue":"6","key":"1550_CR87","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/ana.410350607","volume":"35","author":"AM Connolly","year":"1994","unstructured":"Connolly AM, Dodson WE, Prensky AL, Rust RS. Course and outcome of acute cerebellar ataxia. Ann Neurol. 1994;35(6):673\u20139.","journal-title":"Ann Neurol"},{"issue":"8","key":"1550_CR88","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1177\/0883073816634860","volume":"31","author":"L Kornreich","year":"2016","unstructured":"Kornreich L, Shkalim-Zemer V, Levinsky Y, Abdallah W, Ganelin-Cohen E, Straussberg R. Acute cerebellitis in children: a many-faceted disease. J Child Neurol. 2016;31(8):991\u20137.","journal-title":"J Child Neurol"},{"issue":"6","key":"1550_CR89","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s12311-020-01177-9","volume":"19","author":"N Fadakar","year":"2020","unstructured":"Fadakar N, Ghaemmaghami S, Masoompour SM, Shirazi Yeganeh B, Akbari A, Hooshmandi S, Ostovan VR. A first case of acute cerebellitis associated with coronavirus disease (COVID-19): a case report and literature review. Cerebellum. 2020;19(6):911\u20134.","journal-title":"Cerebellum."},{"issue":"1","key":"1550_CR90","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jemermed.2020.10.010","volume":"60","author":"A Povlow","year":"2021","unstructured":"Povlow A, Auerbach AJ. Acute cerebellar ataxia in COVID-19 infection: a case report. J Emerg Med. 2021;60(1):73\u20136.","journal-title":"J Emerg Med"},{"issue":"1","key":"1550_CR91","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s13104-017-2935-8","volume":"10","author":"A van Samkar","year":"2017","unstructured":"van Samkar A, Poulsen MNF, Bienfait HP, Van Leeuwen RB. Acute cerebellitis in adults: a case report and review of the literature. BMC Res Notes. 2017;10(1):610.","journal-title":"BMC Res Notes"},{"issue":"2","key":"1550_CR92","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1177\/0883073807307973","volume":"23","author":"M Kubota","year":"2008","unstructured":"Kubota M, Takahashi Y. Steroid-responsive chronic cerebellitis with positive glutamate receptor delta 2 antibody. J Child Neurol. 2008;23(2):228\u201330.","journal-title":"J Child Neurol"},{"issue":"7","key":"1550_CR93","doi-asserted-by":"publisher","first-page":"555","DOI":"10.5692\/clinicalneurol.53.555","volume":"53","author":"H Murakami","year":"2013","unstructured":"Murakami H, Iijima S, Kawamura M, Takahashi Y, Ichikawa H. A case of acute cerebellar ataxia following infectious mononucleosis accompanied by intrathecal anti-glutamate receptor \u03b42 antibody. Rinsho Shinkeigaku. 2013;53(7):555\u20138. Japanese","journal-title":"Rinsho Shinkeigaku"},{"issue":"1","key":"1550_CR94","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.braindev.2008.04.010","volume":"31","author":"K Ichikawa","year":"2009","unstructured":"Ichikawa K, Kikuchi M, Takeshita S, Nezu A. A case of chronic recurrent cerebellar ataxia responding to steroid therapy. Brain and Development. 2009;31(1):83\u20135.","journal-title":"Brain and Development"},{"issue":"1","key":"1550_CR95","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0887-8994(03)00420-X","volume":"30","author":"AS Papavasiliou","year":"2004","unstructured":"Papavasiliou AS, Kotsalis C, Trakadas S. Transient cerebellar mutism in the course of acute cerebellitis. Pediatr Neurol. 2004;30(1):71\u20134.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"1550_CR96","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/14734220260418457","volume":"1","author":"Y Sawaishi","year":"2002","unstructured":"Sawaishi Y, Takada G. Acute cerebellitis. Cerebellum. 2002;1(3):223\u20138.","journal-title":"Cerebellum"},{"key":"1550_CR97","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jns.2017.12.035","volume":"385","author":"JF Baizabal-Carvallo","year":"2018","unstructured":"Baizabal-Carvallo JF, Jankovic J. Autoimmune and paraneoplastic movement disorders: an update. J Neurol Sci. 2018;385:175\u201384.","journal-title":"J Neurol Sci"},{"issue":"10","key":"1550_CR98","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00702-020-02238-3","volume":"127","author":"JF Baizabal-Carvallo","year":"2020","unstructured":"Baizabal-Carvallo JF, Cardoso F. Chorea in children: etiology, diagnostic approach and management. J Neural Transm (Vienna). 2020;127(10):1323\u201342.","journal-title":"J Neural Transm (Vienna)"},{"key":"1550_CR99","doi-asserted-by":"publisher","first-page":"e918567","DOI":"10.12659\/AJCR.918567","volume":"21","author":"SD Al-Shokri","year":"2020","unstructured":"Al-Shokri SD, Karumannil SA, Mohammed SS, Sadek MS. Post-Epstein-Barr virus acute cerebellitis in an adult. Am J Case Rep. 2020;21:e918567.","journal-title":"Am J Case Rep"},{"key":"1550_CR100","doi-asserted-by":"publisher","unstructured":"Theeranaew W, Wang F, Ghasia FF, Wilmot G, Shaikh AG. Gaze-holding and anti-GAD antibody: prototypic heterogeneous motor dysfunction in immune disease. Cerebellum. 2021; https:\/\/doi.org\/10.1007\/s12311-021-01272-5.","DOI":"10.1007\/s12311-021-01272-5"},{"issue":"2","key":"1550_CR101","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/brain\/99.2.207","volume":"99","author":"DS Zee","year":"1976","unstructured":"Zee DS, Yee RD, Cogan DG, Robinson DA, Engel WK. Ocular motor abnormalities in hereditary cerebellar ataxia. Brain. 1976;99(2):207\u201334.","journal-title":"Brain."},{"issue":"6","key":"1550_CR102","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1152\/jn.1976.39.6.1246","volume":"39","author":"L Ritchie","year":"1976","unstructured":"Ritchie L. Effects of cerebellar lesions on saccadic eye movements. J Neurophysiol. 1976;39(6):1246\u201356.","journal-title":"J Neurophysiol"},{"issue":"7","key":"1550_CR103","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00415-011-5999-8","volume":"258","author":"M Strupp","year":"2011","unstructured":"Strupp M, Thurtell MJ, Shaikh AG, Brandt T, Zee DS, Leigh RJ. Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus. J Neurol. 2011;258(7):1207\u201322.","journal-title":"J Neurol"},{"key":"1550_CR104","volume-title":"The neurology of eye movements","author":"RJ Leigh","year":"2016","unstructured":"Leigh RJ, Zee DS. The neurology of eye movements. Oxford University Press, NY, NY; 2016. Edition 5"},{"issue":"6","key":"1550_CR105","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1161\/STROKEAHA.120.032488","volume":"52","author":"HA Kim","year":"2021","unstructured":"Kim HA, Oh EH, Choi SY, Choi JH, Park JY, Lee H, Choi KD. Transient vestibular symptoms preceding posterior circulation stroke: a prospective nulticenter study. Stroke. 2021;52(6):e224\u20138.","journal-title":"Stroke."},{"issue":"4","key":"1550_CR106","doi-asserted-by":"publisher","first-page":"441","DOI":"10.5811\/cpcem.2017.6.34772","volume":"1","author":"L Wirfs","year":"2017","unstructured":"Wirfs L, Whitworth K, Kellar J. Nystagmus associated with carbamazepine toxicity. Clin Pract Cases Emerg Med. 2017;1(4):441\u20132.","journal-title":"Clin Pract Cases Emerg Med"},{"issue":"10","key":"1550_CR107","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s10072-013-1315-y","volume":"34","author":"I Adamec","year":"2013","unstructured":"Adamec I, Nankovi\u0107 S, Zadro I, Hajn\u0161ek S, Habek M. Oxcarbazepine-induced jerky see-saw nystagmus. Neurol Sci. 2013;34(10):1839\u201340.","journal-title":"Neurol Sci"},{"issue":"2-3","key":"1550_CR108","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.eplepsyres.2004.11.004","volume":"63","author":"A Alkawi","year":"2005","unstructured":"Alkawi A, Kattah JC, Wyman K. Downbeat nystagmus as a result of lamotrigine toxicity. Epilepsy Res. 2005;63(2-3):85\u20138.","journal-title":"Epilepsy Res"},{"issue":"1","key":"1550_CR109","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00006565-200002000-00008","volume":"16","author":"M Lifshitz","year":"2000","unstructured":"Lifshitz M, Gavrilov V, Sofer S. Signs and symptoms of carbamazepine overdose in young children. Pediatr Emerg Care. 2000;16(1):26\u20137.","journal-title":"Pediatr Emerg Care"},{"issue":"2","key":"1550_CR110","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0002-9394(14)74231-X","volume":"103","author":"GA Chrousos","year":"1987","unstructured":"Chrousos GA, Cowdry R, Schuelein M, Abdul-Rahim AS, Matsuo V, Currie JN. Two cases of downbeat nystagmus and oscillopsia associated with carbamazepine. Am J Ophthalmol. 1987;103(2):221\u20134.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"1550_CR111","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ana.410040516","volume":"4","author":"JN Alpert","year":"1978","unstructured":"Alpert JN. Downbeat nystagmus due to anticonvulsant toxicity. Ann Neurol. 1978;4(5):471\u20133.","journal-title":"Ann Neurol"},{"issue":"15","key":"1550_CR112","doi-asserted-by":"publisher","first-page":"639","DOI":"10.5694\/j.1326-5377.1968.tb83055.x","volume":"2","author":"PJ Landy","year":"1968","unstructured":"Landy PJ. \u201cDilatin\u201d overdosage. Med J Aust. 1968;2(15):639.","journal-title":"Med J Aust"},{"key":"1550_CR113","doi-asserted-by":"publisher","first-page":"155792","DOI":"10.1016\/j.cyto.2022.155792","volume":"151","author":"IK Hals","year":"2022","unstructured":"Hals IK, Bj\u00f6rklund A, Fiskvik Fleiner H, Grill V. Time-dependent effects on circulating cytokines in patients with LADA: a decrease in IL1-ra and IL-1 beta is associated with progressive disease. Cytokine. 2022;151:155792.","journal-title":"Cytokine."},{"issue":"4","key":"1550_CR114","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2337\/db07-1697","volume":"57","author":"C Pfleger","year":"2008","unstructured":"Pfleger C, Mortensen HB, Hansen L, Herder C, Roep BO, Hoey H, Aanstoot HJ, Kocova M, Schloot NC, Hvid\u00f8re Study Group on Childhood Diabetes. Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes. Diabetes. 2008;57(4):929\u201337.","journal-title":"Diabetes."},{"key":"1550_CR115","doi-asserted-by":"publisher","first-page":"616419","DOI":"10.3389\/fneur.2020.616419","volume":"11","author":"A Nigri","year":"2020","unstructured":"Nigri A, Sarro L, Mongelli A, Pinardi C, Porcu L, Castaldo A, et al. Progression of cerebellar atrophy in spinocerebellar ataxia type 2 gene carriers: a longitudinal MRI study in preclinical and early disease stages. Front Neurol. 2020;11:616419.","journal-title":"Front Neurol"},{"issue":"7","key":"1550_CR116","doi-asserted-by":"publisher","first-page":"e11803","DOI":"10.15252\/emmm.201911803","volume":"12","author":"C Wilke","year":"2020","unstructured":"Wilke C, Haas E, Reetz K, Faber J, Garcia-Moreno H, Santana MM, et al. Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in human and mice. EMBO Mol Med. 2020;12(7):e11803.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"1550_CR117","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ana.24872","volume":"81","author":"A Gadoth","year":"2017","unstructured":"Gadoth A, Kryzer TJ, Fryer J, McKeon A, Lennon VA, Pittock SJ. Microtubule-associated protein 1B: novel paraneoplastic biomarker: MAP 1B IgG. Ann Neurol. 2017;81(2):266\u201377.","journal-title":"Ann Neurol"},{"issue":"2","key":"1550_CR118","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","volume":"49","author":"Z Yu","year":"2001","unstructured":"Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol. 2001;49(2):146\u201354.","journal-title":"Ann Neurol"},{"issue":"4","key":"1550_CR119","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/jnnp.2007.138016","volume":"80","author":"J Honnorat","year":"2008","unstructured":"Honnorat J, Cartalat-Carel S, Ricard D, Camdessanche JP, Carpentier AF, Rogemond V, et al. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2\/CRMP5 antibodies. J Neurol Neurosurg Psychiatry. 2008;80(4):412\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1-2","key":"1550_CR120","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jneuroim.2005.03.020","volume":"165","author":"F Graus","year":"2005","unstructured":"Graus F, Vincent A, Pozo-Rosich P, Sabater L, Saiz A, Lang B, et al. Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes. J Neuroimmunol. 2005;165(1-2):166\u201371.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1550_CR121","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ana.20529","volume":"58","author":"SJ Pittock","year":"2005","unstructured":"Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, Stephan CL, et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol. 2005;58(1):96\u2013107.","journal-title":"Ann Neurol"},{"issue":"5","key":"1550_CR122","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1212\/WNL.59.5.764","volume":"59","author":"F Graus","year":"2002","unstructured":"Graus F, Lang B, Pozo-Rosich P, Saiz A, Casamitjana R, Vincent A. P\/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology. 2002;59(5):764\u20136.","journal-title":"Neurology."},{"issue":"2","key":"1550_CR123","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/mus.25027","volume":"54","author":"NL Zalewski","year":"2016","unstructured":"Zalewski NL, Lennon VA, Lachance DH, Klein CJ, Pittock SJ, Mckeon A. P\/Q- and N-type calcium-channel antibodies: oncological, neurological, and serological accompaniments: neuronal Calcium-Channel Abs. Muscle Nerve. 2016;54(2):220\u20137.","journal-title":"Muscle Nerve"},{"issue":"12","key":"1550_CR124","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/jnnp.2006.097188","volume":"77","author":"L Sabater","year":"2006","unstructured":"Sabater L, Bataller L, Carpentier AF, Aguirre-Cruz ML, Saiz A, Benyahia B, et al. Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer. J Neurol Neurosurg Psychiatry. 2006;77(12):1359\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1-2","key":"1550_CR125","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jneuroim.2012.12.002","volume":"256","author":"R H\u00f6ftberger","year":"2013","unstructured":"H\u00f6ftberger R, Kovacs GG, Sabater L, Nagy P, Racz G, Miquel R, et al. Protein kinase C\u03b3 antibodies and paraneoplastic cerebellar degeneration. J Neuroimmunol. 2013;256(1-2):91\u20133.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"1550_CR126","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/ana.20238","volume":"56","author":"L Bataller","year":"2004","unstructured":"Bataller L, Sabater L, Saiz A, Serra C, Claramonte B, Graus F. Carbonic anhydrase-related protein VIII: autoantigen in paraneoplastic cerebellar degeneration. Ann Neurol. 2004;56(4):575\u20139.","journal-title":"Ann Neurol"},{"issue":"5","key":"1550_CR127","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/nan.12118","volume":"40","author":"R H\u00f6ftberger","year":"2014","unstructured":"H\u00f6ftberger R, Sabater L, Velasco F, Ciordia R, Dalmau J, Graus F. Carbonic anhydrase-related protein VIII antibodies and paraneoplastic cerebellar degeneration. Neuropathol Appl Neurobiol. 2014;40(5):650\u20133.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1550_CR128","doi-asserted-by":"publisher","first-page":"577242","DOI":"10.1016\/j.jneuroim.2020.577242","volume":"344","author":"A Prevezianou","year":"2020","unstructured":"Prevezianou A, Tzartos JS, Dagklis IE, Bentenidi E, Angelopoulos P, Bostantjopoulou S. Paraneoplastic cerebellar degeneration in a patient with breast cancer associated with carbonic anhydrase-related protein VIII autoantibodies. J Neuroimmunol. 2020;344:577242.","journal-title":"J Neuroimmunol"},{"key":"1550_CR129","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3389\/fneur.2018.00656","volume":"9","author":"F Bartels","year":"2018","unstructured":"Bartels F, Pr\u00fcss H, Finke C. Anti-ARHGAP26 autoantibodies are associated with isolated cognitive impairment. Front Neurol. 2018;9:656.","journal-title":"Front Neurol"},{"issue":"18","key":"1550_CR130","doi-asserted-by":"publisher","first-page":"e1677","DOI":"10.1212\/WNL.0000000000006435","volume":"91","author":"E Basal","year":"2018","unstructured":"Basal E, Zalewski N, Kryzer TJ, Hinson SR, Guo Y, Dubey D, et al. Paraneoplastic neuronal intermediate filament autoimmunity. Neurology. 2018;91(18):e1677\u201389.","journal-title":"Neurology."},{"issue":"2","key":"1550_CR131","doi-asserted-by":"publisher","first-page":"e326","DOI":"10.1212\/NXI.0000000000000326","volume":"4","author":"G Berzero","year":"2017","unstructured":"Berzero G, Hacohen Y, Komorowski L, Scharf M, Dehais C, Leclercq D, et al. Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies. Neurol Neuroimmunol Neuroinflamm. 2017;4(2):e326.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"1550_CR132","doi-asserted-by":"publisher","first-page":"e418","DOI":"10.1212\/NXI.0000000000000418","volume":"5","author":"N Alfugham","year":"2018","unstructured":"Alfugham N, Gadoth A, Lennon VA, Komorowski L, Scharf M, Hinson S, et al. ITPR1 autoimmunity: frequency, neurologic phenotype, and cancer association. Neurol Neuroimmunol Neuroinflamm. 2018;5(1):e418.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"1550_CR133","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ana.1127","volume":"50","author":"KH Chan","year":"2001","unstructured":"Chan KH, Vernino S, Lennon VA. ANNA-3 anti-neuronal nuclear antibody: Marker of lung cancer-related autoimmunity. Ann Neurol. 2001;50(3):301\u201311.","journal-title":"Ann Neurol"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-023-01550-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-023-01550-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-023-01550-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T09:16:30Z","timestamp":1710839790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-023-01550-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":133,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["1550"],"URL":"https:\/\/doi.org\/10.1007\/s12311-023-01550-4","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"20 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Committee Approval"}},{"value":"All subjects provided consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All subjects provided consent to publication of the findings in medical journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}